SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-025839
Filing Date
2021-02-02
Accepted
2021-02-02 16:01:57
Documents
14
Period of Report
2021-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d90144d8k.htm   iXBRL 8-K 31109
2 EX-10.1 d90144dex101.htm EX-10.1 243404
6 GRAPHIC g90144dsp49.jpg GRAPHIC 49149
  Complete submission text file 0001193125-21-025839.txt   527709

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krys-20210129.xsd EX-101.SCH 3074
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20210129_lab.xml EX-101.LAB 18886
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20210129_pre.xml EX-101.PRE 11862
7 EXTRACTED XBRL INSTANCE DOCUMENT d90144d8k_htm.xml XML 3446
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 21581341
SIC: 2836 Biological Products, (No Diagnostic Substances)